Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial of Grazax in Subjects With Hayfever

This study has been completed.
Information provided by:
ALK-Abelló A/S Identifier:
First received: January 11, 2007
Last updated: June 23, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):